Collaborations:

---

We believe innovation thrives through collaboration. IFDO actively partners with a range of stakeholders to advance digital oncology:

Academic Partners:
We are looking forward to collaborating with leading academic, research and clinical institutions, oncologists, day care centres, private players, companies working in the field across screening, diagnostics, devices, equipment’s, treatment, clinical trials and the entire value chain.

Industry Collaborations:

IFDO partners with digital health startups, pharma, and med-tech companies to bring innovations into real-world cancer care. We pilot emerging tools in clinical settings, provide feedback, and support integration into care workflows. From using wearables in drug trials to advising on AI software deployment, we ensure solutions are evidence-based, user-friendly, and patient-centered. Our forums connect clinicians and developers to foster collaboration—with strict conflict-of-interest policies in place to uphold ethical standards.

International Networks:
Cancer knows no borders, and neither do we. IFDO is looking forward to forging links with sister organizations and societies across the world to share best practices and even co-develop initiatives.

Government and Policy Bodies:
We collaborate with health authorities to align with national digital health goals, offering expert input to shape policies, support pilot programs, and enable the safe, timely adoption of digital innovations in routine care.